https://www.selleckchem.com/pr....oducts/methylene-blu
3rd) influence cortical responding during an NLE task. Apatinib showed efficacy in non-small cell lung cancer (NSCLC). We conducted this phase II clinical study to assess the efficacy and safety of apatinib in combination with pemetrexed-platinum chemotherapy in non-squamous NSCLC (Clinical Trial Registration ChiCTR180001592. Patients received oral apatinib (250 mg/d) with intravenous pemetrexed (500 mg/m )-platinum (carboplatin AUC = 5 or cisplatin 75 mg/m ) chemotherapy every 21 days for 6 treatment cycles, and the
Kao
Komentar
Udio
